The half-life of thymidine kinase 1 in serum measured by ECL dot blot: A potential marker for monitoring the response to surgery of patients with gastric cancer

International Journal of Biological Markers

Volumn 17, Issue 2, 2002, Pages 135-140

  Zou, L ^a   Zhang, P G ^a   Zou, S ^a   Li, Y ^a   He, Qimin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Enhanced chemiluminescent (ECL) dot blot; Gastric cancer (GC); Half life; STK1 activity; Thymidine kinase 1 (TK1); Thymidine kinase 1 in serum (STK1)

Indexed keywords

BIOLOGICAL MARKER; DACARBAZINE; FLUOROURACIL; THYMIDINE KINASE; THYMIDINE KINASE 1; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; GASTRECTOMY; HUMAN; METASTASIS; PATIENT MONITORING; PLASMA HALF LIFE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RADIOACTIVITY; REFERENCE VALUE; STOMACH CANCER; TREATMENT OUTCOME; BLOOD; ENZYMOLOGY; HALF LIFE TIME; STOMACH TUMOR; WESTERN BLOTTING;

BLOTTING, WESTERN; CHEMILUMINESCENT MEASUREMENTS; HALF-LIFE; HUMANS; STOMACH NEOPLASMS; THYMIDINE KINASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0035986105     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.1382     Document Type: Article

References (16)

1. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer
2. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19.9 in patients with gastric cancer
3. Regulation of human thymidine kinase during the cell cycle
4. Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours
5. Cell cycle regulation of thymidine kinase: Residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis
6. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells
7. Application of an in vivo assay for serum thymidine kinase: Results on viral disease and malignancies in humans
8. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia
9. Thymidine kinase 1 immunoassay: A potential marker for breast cancer
10. The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody
11. Characterisation of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation
12. Specific recognition of cytosolic thymidine kinase in the human lung tumor by monoclonal antibody raised against recombinant human thymidine kinase
13. Comparison study on the expression of cytosolic thymidine kinase and proliferating cell nuclear antigen in colorectal carcinoma
14. A comparison study: Immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer
15. Investigation on cell proliferation with a new antibody against thymidine kinase 1
16. Expression of nm23 in the primary tumor and the metastatic regional nodes of patients with gastric cardiac cancer